Hepatitis B: the silent liver virus with a vaccine and a plan
Last updated September 3, 2026.
Hepatitis B is a viral liver infection spread through blood and body fluids: often silent for years, sometimes causing acute illness, and in a minority becoming a chronic infection that needs lifelong monitoring. Two facts frame everything: there is a highly effective vaccine, and chronic hepatitis B, while serious, is managed successfully with regular checks and antiviral medication that protects the liver for decades.
What does it feel like?
Acute infection, when symptomatic at all (many cases are silent): weeks of fatigue, nausea, poor appetite, vague abdominal discomfort, then sometimes jaundice (yellow skin and eyes), dark urine, and pale stools. Most adults clear the virus completely within months. Chronic hepatitis B (about 5% of adult infections, but the large majority of infections caught at birth or in early childhood) usually has no symptoms for years or decades, which is exactly why testing and monitoring matter: the liver can be quietly inflamed while you feel entirely well.
How does it spread?
Through blood and body fluids: from mother to baby at birth (the commonest route worldwide and the reason for birth-dose vaccination), unprotected sex, shared needles and syringes, needlestick injuries, shared razors or toothbrushes with blood on them, unsterile tattooing and piercing, and medical procedures with unscreened blood or unsterile equipment (historically and in some regions). It is not spread by hugging, sharing food, coughing, or breastfeeding with proper precautions, and casual contact carries no risk.
What actually happens after diagnosis?
- Acute infection: supportive care while the body clears it; most adults recover fully and become immune.
- Chronic infection: regular monitoring: blood tests (liver function, viral load) and ultrasound surveillance (because chronic infection raises liver-cancer risk, typically 6-monthly scans in higher-risk groups), even when you feel well.
- Antivirals when indicated: tenofovir or entecavir suppress the virus effectively (treatment is usually long-term), protecting the liver from scarring; started when viral activity or liver damage markers cross thresholds.
- Protect the liver: minimal or no alcohol, a healthy weight (fatty liver compounds the injury), and hepatitis A vaccination to avoid a second liver hit.
- Protect others: household and sexual partners get tested and vaccinated; condoms until partners are immune; never share needles, razors, or toothbrushes; and pregnant women with hepatitis B get a specific plan (birth-dose vaccine plus immunoglobulin protects the baby almost completely).
When is it an emergency?
Most hepatitis B is clinic medicine. Urgent versions: acute hepatitis with confusion, severe drowsiness, or bleeding (rare acute liver failure: an emergency), jaundice with severe vomiting and inability to keep fluids down, and any hepatitis in pregnancy (needs prompt specialist care for both mother and baby). For chronic carriers, new jaundice, abdominal swelling, vomiting blood, or confusion are same-day signs of advancing liver disease. Pymander's escalation routing is built and tested specifically for this class of decision; see the safety architecture working paper.
What a Pymander AI doctor consult looks like
Illustrative example, not a real member's messages.
Common questions
I feel fine. Is the diagnosis real, and does it matter?
Real, and it matters precisely because you feel fine: chronic hepatitis B typically causes no symptoms for decades while quietly inflaming and scarring the liver, so the first symptom of unmanaged infection can be advanced disease, which is the entire reason screening finds it early. A positive test starts a mapping process (how active is the virus, how healthy is the liver), not an emergency. The framed truth: feeling well with chronic hepatitis B is the normal state, it is manageable for a full lifespan, and the monitoring is what keeps it that way.
How did I get it without knowing?
The likeliest answer is at birth or in early childhood: mother-to-child transmission at delivery is the commonest route worldwide, and childhood infections almost always go unnoticed (children rarely get the jaundice phase) yet usually become chronic, the opposite of adult infection, which is usually cleared. Other routes (unprotected sex, shared needles, unsterile tattoos or medical equipment) are often untraceable in retrospect. The unknowability of the timing is normal and changes nothing about management; the useful family implication is that your mother, siblings, and children merit testing, because household patterns run along exactly those lines.
Will I need medication forever?
It depends on the virus's activity: many people with chronic hepatitis B need only monitoring (blood tests and ultrasounds on schedule) for years or life, because their virus is quiet and their liver healthy. Antiviral treatment (tenofovir or entecavir, one tablet daily) starts when viral activity or liver-enzyme patterns cross set thresholds, and when it starts it is usually long-term, because the drugs suppress rather than eradicate the virus. The drugs are well tolerated and effective: treated patients' liver risks fall dramatically. Stopping treatment without the specialist's say-so risks flares, which is the one rule to hold.
Can I pass it to my partner or children?
Yes, but the protection is excellent: sexual partners and household contacts should be tested, and if negative, vaccinated, which protects them completely; condoms until vaccination confirms immunity. At birth, a baby whose mother carries hepatitis B receives the vaccine plus immunoglobulin within hours, which prevents transmission in the overwhelming majority of cases, one of the great public-health wins, so pregnancy is absolutely compatible with motherhood with the right plan. Day-to-day: no sharing razors, toothbrushes, or needles; cover cuts; and know that hugging, kissing, sharing meals, and ordinary household life do not transmit it.
What does the monitoring actually involve?
A rhythm, not a burden: blood tests every 6-12 months (liver enzymes to detect inflammation, viral load to track activity, sometimes fibrosis scores), plus liver ultrasound surveillance for those in higher-risk groups (typically men over 40, women over 50, cirrhosis, or family history of liver cancer, often 6-monthly), because chronic infection raises liver-cancer risk and ultrasound catches it early and treatable. Some clinics add elastography (a fibrosis-scan) periodically. The appointments are short, the stakes they guard are high, and the patients who do best are simply the ones who keep coming.
Is there a cure for hepatitis B?
Not yet, honestly: current antivirals suppress the virus extremely effectively (viral load to undetectable, liver protected, complication risks slashed), but they rarely eliminate it completely, so treatment is long-term and monitoring continues even on therapy. A small minority of chronic carriers do clear the virus naturally each year. Cure research is active (several strategies in trials targeting the viral reservoir), and the landscape is genuinely more hopeful than a decade ago. In the present tense: suppression plus surveillance delivers a normal lifespan and a healthy liver for the large majority, and that is the plan to commit to.